Literature DB >> 16923753

Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.

Carson S Webb1, David D Bonnema, S Hinan Ahmed, Amy H Leonardi, Catherine D McClure, Leslie L Clark, Robert E Stroud, William C Corn, Laura Finklea, Michael R Zile, Francis G Spinale.   

Abstract

BACKGROUND: Changes in matrix metalloproteinase (MMP) and tissue inhibitors of MMPs (TIMPs) contribute to left ventricular (LV) remodeling after myocardial infarction (MI). We tested the hypothesis that a specific plasma MMP/TIMP profile would emerge after MI and be associated with the degree of LV dilation. METHODS AND
RESULTS: LV end-diastolic volume and MMP/TIMP plasma profiles were determined in 53 age-matched control subjects and 32 post-MI patients from day 1 through 180 after MI. LV end-diastolic volume increased by > 38% at day 90 after MI (P < 0.05). MMP-9 increased by > 150% from control at day 1 after MI (P < 0.05) and remained elevated. MMP-8 rose to > 120% at day 3 after MI (P < 0.05) and fell to control values by day 5. TIMP-1 increased by > 60% from control at day 1 after MI (P < 0.05), whereas TIMP-2 increased only at later time points. Cardiac-specific TIMP-4 fell by 40% at day 5 after MI and remained reduced. A persistent or elevated MMP-9 at day 5 was accompanied by a 3-fold end-diastolic volume increase at day 28 (P < 0.05).
CONCLUSIONS: A specific temporal pattern of MMP/TIMPs occurred in post-MI patients that included an early and robust rise in MMP-9 and MMP-8 and a uniform fall in TIMP-4. These findings suggest that a specific MMP/TIMP plasma profile occurs after MI and holds both prognostic and diagnostic significance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923753     DOI: 10.1161/CIRCULATIONAHA.105.600353

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  71 in total

1.  Induction of cardiomyocyte apoptosis by anti-cardiac myosin heavy chain antibodies in patients with acute myocardial infarction.

Authors:  Kun Liu; Liang Shao; Li Wang; Yanping Ding; Guanhua Su; Jue Wang; Yuhua Liao; Zhaohui Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

2.  Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.

Authors:  Michael R Zile; Shannon M Mehurg; Jazmine E Arroyo; Robert E Stroud; Stacia M DeSantis; Francis G Spinale
Journal:  Circ Cardiovasc Genet       Date:  2011-09-28

Review 3.  Imaging of matrix metalloproteinase activation and left ventricular remodeling.

Authors:  Grace Chung; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

4.  Matrix metalloproteinase therapy in heart failure.

Authors:  Francis G Spinale; Nikole M Wilbur
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08

5.  A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Rogelio Zamilpa; Andriy Yabluchanskiy; Kristine Y DeLeon-Pennell; Michael E Hall; Abdullah Kaplan; Fouad A Zouein; Dustin Bratton; Elizabeth R Flynn; Presley L Cannon; Yuan Tian; Yu-Fang Jin; Richard A Lange; Dorota Tokmina-Roszyk; Gregg B Fields; Lisandra E de Castro Brás
Journal:  J Am Coll Cardiol       Date:  2015-09-22       Impact factor: 24.094

6.  Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction.

Authors:  Shaina R Eckhouse; Brendan P Purcell; Jeremy R McGarvey; David Lobb; Christina B Logdon; Heather Doviak; Jason W O'Neill; James A Shuman; Craig P Novack; Kia N Zellars; Sara Pettaway; Roy A Black; Aarif Khakoo; Taeweon Lee; Rupak Mukherjee; Joseph H Gorman; Robert C Gorman; Jason A Burdick; Francis G Spinale
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

7.  Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation.

Authors:  Naoko Sasaki; Yasuo Okumura; Ichiro Watanabe; Hiroaki Mano; Koichi Nagashima; Kazumasa Sonoda; Rikitake Kogawa; Kimie Ohkubo; Toshiko Nakai; Atsushi Hirayama
Journal:  J Interv Card Electrophysiol       Date:  2014-02-20       Impact factor: 1.900

8.  Effects of exercise training on cardiac function and myocardial remodeling in post myocardial infarction rats.

Authors:  Xiaohua Xu; Wenhan Wan; Anthony S Powers; Ji Li; Lisa L Ji; Shunhua Lao; Bryan Wilson; John M Erikson; John Q Zhang
Journal:  J Mol Cell Cardiol       Date:  2007-10-12       Impact factor: 5.000

9.  Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.

Authors:  David C Lobb; Heather Doviak; Gregory L Brower; Eva Romito; Jason W O'Neill; Stephen Smith; James A Shuman; Parker D Freels; Kia N Zellars; Lisa A Freeburg; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  J Pharmacol Exp Ther       Date:  2020-09-21       Impact factor: 4.030

10.  Dynamic changes in matrix metalloprotienase activity within the human myocardial interstitium during myocardial arrest and reperfusion.

Authors:  Francis G Spinale; Christine N Koval; Anne M Deschamps; Robert E Stroud; John S Ikonomidis
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.